The Critical Importance of Early FRAT® (Folate Receptor Autoantibody Test) Screening
Early FRAT® screening detects folate receptor autoantibodies linked to autism and CFDS, enabling timely treatment to improve cognitive and developmental outcomes.
Autism in the United States has surged and continues to grow at an alarming rate. The CDC reports that 1 in 36 children have been identified with autism spectrum disorder (ASD). Folate Receptor Autoantibodies have been found to be highly prevalent in children with ASD. The folate receptor alpha (FRa) is responsible for actively transporting folate into several body organs including the fetus and brain. Folate Receptor Autoantibodies interfere with the ability of the FRa to function properly, thereby affecting folate transport. This condition may be treated with alternate reduced folates. Early diagnosis can lead to earlier intervention and possibly greater improvement. Please consult your physician for more information.

FRAT® is a vital blood test that screens for Folate Receptor Autoantibodies, which hinder the proper transport of essential folate (vitamin B9) to the brain and Cerebrospinal Fluid (CSF). This deficiency can contribute to Cerebral Folate Deficiency Syndrome, among other neurodevelopmental and neuropsychiatric disorders.

A large percentage of children with Autism have been found to have Folate Receptor Autoantibodies. FRAT® will confirm the presence of these autoantibodies, which suggests that not enough folate (vitamin B9) is being transported into the brain.

Don't wait to take action! Early diagnosis is the key to optimal treatment outcomes. With the information provided by FRAT®, you and your physician can explore alternate reduced folate treatments that can make a real difference!

Insufficient folate can often be corrected with alternate folate metabolites that bypass the autoantibodies. Consult your physician for further information on available therapeutic approaches.
Early FRAT® screening detects folate receptor autoantibodies linked to autism and CFDS, enabling timely treatment to improve cognitive and developmental outcomes.
Learn how FRα autoantibodies impair folate transport across the BBB, causing cerebral folate deficiency and impacting brain development and function.
Phosphorus fuels life and energy. Learn its role in DNA, ATP, health, environmental impact, and why this essential element shapes our future.
Early FRAT® testing detects folate receptor autoantibodies, enabling timely treatment to prevent neurological damage and improve outcomes in autism and related disorders.
Learn about Pathological Demand Avoidance (PDA) in autism—key signs, causes, and practical strategies to support individuals and reduce daily challenges.
Iodine, the violet element, drives thyroid hormones, brain development, and metabolism. Learn why this micronutrient shapes human health worldwide.
New Swedish research reveals why autism diagnoses differ between males and females and how awareness is closing the gender gap in autism spectrum disorder.
A new autism theory links symptoms to brain energy deficits. Discover how impaired glucose metabolism may affect behavior, speech, and sensory processing.
Understand the overlap between autism and migraine, including neuroinflammation, mitochondrial function, and folate transport.
Leucovorin may help ASD with FRAAs by bypassing blocked folate transport to the brain. Learn how folinic acid supports communication and treats cerebral folate deficiency.
Understand the neurological link between autism and migraine through key pathways like neuroinflammation, mitochondrial function and folate transport.
FRAT® test detects folate receptor autoantibodies linked to autism, cerebral folate deficiency, and NTDs—enabling early diagnosis and targeted folinic acid treatment.
Explore how folate receptor alpha autoantibodies (FRAAs) disrupt brain folate transport and contribute to autism spectrum disorder, cerebral folate deficiency, and targeted treatment insights.
FRAT® testing prior to leucovorin therapy ensures accurate diagnosis, personalized dosing, and better outcomes in cerebral folate deficiency and ASD.
Discover why zinc is vital for immunity, growth, fertility, brain health, and enzyme function—and how deficiency affects billions worldwide.
Rising autism prevalence and the FDA approval of leucovorin highlight a targeted metabolic approach for ASD linked to cerebral folate deficiency.
Leucovorin demand is rising in ASD care. Learn why folic acid is not an alternative and may worsen cerebral folate deficiency.